With the widespread use of highly active anti-retroviral treatment (HAART), HIV has become a chronic, rather than a fatal, disease. But for their treatment to succeed, patients require uninterrupted care from a health care provider and uninterrupted access to anti-HIV medications. The IOM identifies federal, state, and private health insurance policies that inhibit HIV-positive individuals from initiating or continuing their care.

Contents

• THE NATIONAL ACADEMIES
• COMMITTEE ON HIV SCREENING AND ACCESS TO CARE
• Reviewers
• Abbreviations and Acronyms
• Abstract
• HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care
  • Report Organization
  • BACKGROUND
  • POLICIES THAT PROMOTE OR INHIBIT CLINICAL CARE SERVICES AMONG AGENCIES AT THE FEDERAL LEVEL, STATE LEVEL, OR BETWEEN FEDERAL AND STATE AGENCIES
  • HOW FEDERAL AND STATE AGENCIES CAN PROVIDE MORE INTEGRATED HIV CARE SERVICES
  • HIV MEDICATION ADHERENCE PROGRAMS
  • PAYMENT FOR TREATMENT OF EARLIER STAGE HIV INFECTION
  • CONCLUSIONS
  • REFERENCES
• A Biographical Sketches of Committee Members
• B Workshop Agenda
• C Biographical Sketches of Workshop Speakers
• D Workshop Attendees

This study was supported by Contract No. HHSP23320042509XI between the National Academy of Sciences and the White House Office of National AIDS Policy. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.

Suggested citation:

IOM (Institute of Medicine). 2011. HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care. Washington, DC: The National Academies Press.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.